Onyx Biotec Complete Financial Statements

ONYX • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022

Complete Financial Data Export

Export complete financial statements for Onyx Biotec (ONYX). Downloads include all available records across all periods. For market performance, see the ONYX stock price today .

Profitability Ratios

Net Profit Margin 7.94% 2025 data
EBITDA Margin 19.05% 2025 data
Operating Margin 17.00% 2025 data
Return on Assets 5.49% 2025 data
Return on Equity 8.93% 2025 data

Balance Sheet Ratios

Current Ratio 4.90 2025 data
Debt to Equity 1.63 2025 data
Equity Ratio 61.54% 2025 data
Asset Turnover 0.69 2025 data

Year-over-Year Growth Analysis

Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+23.0%
Year-over-Year
Equity Growth
+124.0%
Year-over-Year
Liabilities Growth
+23.0%
Year-over-Year
Operating Cash Flow Growth
-50.0%
Year-over-Year
Investing Cash Flow Growth
+133.3%
Year-over-Year
Financing Cash Flow Growth
+66.7%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022
Revenue 0 63 54 40 45
Expenses 0 52 45 35 39
EBITDA 0 12 9 5 6
Operating Profit Margin % 0.00% 17.00% 16.00% 11.00% 13.00%
Depreciation 0 3 2 2 1
Interest 0 2 2 1 1
Profit Before Tax 0 7 5 3 4
Tax 0 2 1 1 0
Net Profit 0 5 4 2 3
Earnings Per Share (₹) 0.00 3.31 3.05 1.56 2.84

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022
ASSETS
Total Assets 91 74 59 37
Current Assets 49 30 15 14
Fixed Assets 41 44 43 17
Capital Work in Progress 0 0 0 4
Investments 0 0 0 0
Other Assets 50 31 16 16
LIABILITIES
Total Liabilities 91 74 59 37
Current Liabilities 10 26 20 10
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 56 25 18 16
Share Capital 18 13 6 6
Reserves & Surplus 38 12 12 11

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022
Operating Activities 1 2 2 1
Investing Activities 1 -3 -23 -6
Financing Activities 5 3 16 5
Net Cash Flow 7 2 -4 0